Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review

References

• AbramsLSSkeeDMNatarajanJ2001Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra™/Evra™) under conditions of heat, humidity and exerciseJ Clin Pharmacol411301911762557
   PubMed Web of Science ®Google Scholar
• ArcherDFBigriggASmallwoodGH2002Assessment of compliance with a weekly contraceptive patch (Ortho Evra™/Evra™) among North American womenFertil Steril772, Suppl 2S27S3011849633
   PubMed Web of Science ®Google Scholar
• ArcherDFCullinsVCreasyGW2004The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra®) on contraceptive efficacyContraception691899514969665
   PubMed Web of Science ®Google Scholar
• AudetMCMoreauMKoltunWD2001Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive. A randomized controlled trialJAMA28523475411343482
   PubMed Web of Science ®Google Scholar
• BurkmanRT2007Transdermal hormonal contraception: benefits and risksAm J Obstet Gynecol197134e1617689623
   PubMed Web of Science ®Google Scholar
• CaputoRBarbareschiMLunardonL2005A patch-released norelgestromin and ethinyl estradiol association in the treatment of papulo-pustular inflammatory acneG Ital Dermatol Venereol14072732
   Google Scholar
• ColeJANormanHDohertyM2007Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system usersObstet Gynecol1093394617267834
   PubMed Web of Science ®Google Scholar
• Collaborative Group on Epidemiological Studies of Ovarian Cancer2008Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controlsLancet3713031418294997
   PubMed Web of Science ®Google Scholar
• CramerJARoyABurrellA2008Medication compliance and persistence: terminology and definitionsValue Health1144718237359
   PubMed Web of Science ®Google Scholar
• CreasyGWAbramsLSFisherAC2001Transdermal contraceptionSemin Reprod Med193738011727179
   PubMed Web of Science ®Google Scholar
• DittrichRParkerLRosenJB2002Transdermal contraception: evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a ranmdomised, multicenter, dose-response studyAm J Obstet Gynecol186152011810078
   PubMed Web of Science ®Google Scholar
• D’SouzaREGuillebaudJ2002Risks and benefits of oral contraceptive pillsBest Pract Res Clin Obstet Gynecol1613354
   Web of Science ®Google Scholar
• FrenchL2008Dysmenorrhea in adolescents: diagnosis and treatmentPaediatr Drugs101718162003
   PubMedGoogle Scholar
• GalloMFLopezLMGrimesDA2006Combination contraceptives: effects on weightCochrane Database of Systematic ReviewsIssue 1 Art. No: CD00398710.1002/14651858.CD003987.pub2
   Web of Science ®Google Scholar
• GrinspoonSKFriedmanAJMillerKK2003Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrheaJ Clin Endocrinol Metab883651612915650
   PubMed Web of Science ®Google Scholar
• HannafordPCSelvarajSElliottAM2007Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner’s oral contraception studyBMJ335651917855280
   PubMed Web of Science ®Google Scholar
• HarelZRiggsSVazR2005Adolescents’ experience with the combined estrogen and progestin transdermal contraceptive method Ortho EvraJ Pediatr Adolesc Gynecol18859015897103
   PubMedGoogle Scholar
• HedonBHelmerhorstFMCronjeHS2000Comparison of efficacy, cycle control, compliance, and safety in users of a contraceptive patch vs an oral contraceptiveInt J Gynecol Obstet70Suppl 178
   Google Scholar
• JakimiukAMadelenetPChernevT2006aEfficacy and tolerability of transdermal hormonal contraception over 6 monthsEur J Contracept Reprod Health Care11S1P024,667
   Google Scholar
• JakimiukAMadelenetPChernevT2006bTransdermal contraception is associated with high levels of patient satisfaction and complianceEur J Contracept Reprod Health Care11S1P028,689
   Google Scholar
• JensenJTSperoffL2000Health benefits of oral contraceptivesObstet Gynecol Clin North Am277052111091985
   PubMed Web of Science ®Google Scholar
• JickSSJickH2006Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patchContraception74290216982227
   PubMed Web of Science ®Google Scholar
• JickSSKayeJARussmannS2006Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 mcg of ethinyl estradiolContraception73223816472560
   PubMed Web of Science ®Google Scholar
• JickSSJickH2007The contraceptive patch in relation to ischemic stroke and acute myocardial infarctionPharmacotherapy272182017253912
   PubMed Web of Science ®Google Scholar
• JickSKayeJALiL2007Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 mcg of ethinyl estradiolContraception764717586129
   PubMed Web of Science ®Google Scholar
• JohnsonJVLowellJBadgerGJ2008Effects of oral and transdermal hormonal contraception on vascular risk markersObstet Gynecol111270283
   Web of Science ®Google Scholar
• KaunitzAM2001Oral contraceptive use in perimenopauseAm J Obstet Gynecol185S32711521120
   PubMed Web of Science ®Google Scholar
• KluftCMeijerPLaGuardiaKD2008Comparison of a transdermal contraceptive patch vs oral contraceptives on hemostasis variablesContraception77778318226669
   PubMed Web of Science ®Google Scholar
• LeteIDovalJLPérez-CamposE2007Factors affecting women’s selection of a combined hormonal contraceptive method: the TEAM-06 Spanish cross-sectional studyContraception76778317656174
   PubMed Web of Science ®Google Scholar
• LippmanJSShangoldGA1997A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiolInt J Fertil422309
   Google Scholar
• LogsdonSRichardsJOmarHA2004Long-term evaluation of the use of the transdermal contraceptive patch in adolescentsThe Scientific World45126
   Google Scholar
• LopezLMGrimesDAGalloMF2008Skin patch and vaginal ring versus combined oral contraceptives for contraceptionCochrane Database of Systematic ReviewsIssue 1 Art. No: CD00355210.1002/14651858.CD003552.pub2
   Web of Science ®Google Scholar
• MillerWB1986Why some women fail to use their contraceptive method: a psychological investigationFam Plann Perspect1827323803546
   PubMedGoogle Scholar
• O’ConnellKBurkmanRT2007The transdermal contraceptive patch: an updated review of the literatureClin Obstet Gynecol509182617982334
   PubMed Web of Science ®Google Scholar
• ParisFRabeolinaFBalaguerP2007Antiandrogenic activity of norgestimate in a human androgen-dependent stable transfected cell lineGynecol Endocrinol23193717505938
   PubMed Web of Science ®Google Scholar
• PetittiDB2003Combination estrogen-progestin oral contraceptivesN Engl J Med34944350
   Web of Science ®Google Scholar
• PiersonRAArcherDFMoreauM2003Ortho Evra™/Evra™ versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing errorFertil Steril80344212849799
   PubMed Web of Science ®Google Scholar
• PiyasirisilpRTaneepanichskulS2008A clinical study of transdermal contraceptive patch in Thai adolescence womenJ Med Assoc Thai911374118389975
   PubMedGoogle Scholar
• PonsJEHormonal contraception compliance in teenagers2006Pediatr Endocrinol Rev3Suppl 1164616641852
   PubMedGoogle Scholar
• PotterLOakleyDDe Leon-WongE1996Measuring compliance among oral contraceptive usersFam Plann Perspect2815488853280
   PubMedGoogle Scholar
• ProbstfieldJLCramerJASpilkerBThe clinical trial pre-randomization compliance (adherence) screen1991Patients compliance in medical practice and clinical trialsNew YorkRaven Press32334
   Google Scholar
• PrausnitzMRMitragotriSLangerR2004Current status and future potential of transdermal drug deliveryNature Rev Drug Discov31152415040576
   PubMed Web of Science ®Google Scholar
• RabeTKowaldAOrtmannJ2000Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitroGynecol Endocrinol142233011075290
   PubMed Web of Science ®Google Scholar
• RamaRaoSLacuestaMCostelloM2003The link between quality of care and contraceptive useInt Fam Plan Perspect29768312783771
   PubMedGoogle Scholar
• RaschVKnudsenLBGammeltoftT2007Contraceptive attitudes and contraceptive failure among women requesting induced abortion in DenmarkHum Reprod221320617296620
   PubMed Web of Science ®Google Scholar
• RodgersAKFalconeT2008Treatment strategies for endometriosisExpert Opin Pharmacother92435518201147
   PubMed Web of Science ®Google Scholar
• RosenbergMJWaughMSMeehanTE1995Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuationContraception5128387628201
   PubMed Web of Science ®Google Scholar
• RosenbergMJWaughMSBurnhillMS1998Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluationFam Plann Perspect30289929561874
   PubMedGoogle Scholar
• RubinsteinMLHalpern-FelsherBLIrwinCE2004An evaluation of the use of the transdermal contraceptive patch in adolescentsJ Adolesc Health3439540115093794
   PubMed Web of Science ®Google Scholar
• SackettDLSackettDLHaynesRBIntroduction1976Compliance with therapeutic regimensBaltimoreJohns Hopkins University Press
   Google Scholar
• SatorPGSchmidtJBHonigsmannH2003Clinical evidence of the endocrinological influence of a triphasic oral contraceptive containing norgestimate and ethinyl estradiol in treating women with acne vulgarisDermatology206241812673082
   PubMed Web of Science ®Google Scholar
• Schmidt-SarosiC1998Infertility in the older womanClin Obstet Gynecol41940509917949
   PubMed Web of Science ®Google Scholar
• SibaiBMOdlindVMeadorML2002A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra™/Evra™)Fertil Steril77Suppl 2S19S2611849632
   PubMed Web of Science ®Google Scholar
• SmallwoodGHMeadorMLLenihanJP2001Efficacy and safety of a transdermal contraceptive systemObstet Gynecol9879980511704172
   PubMed Web of Science ®Google Scholar
• SmithJDOakleyD2005Why do women miss oral contraceptive pills? An analysis of women’s self-described reasons for missed pillsJ Midwifery Womens Health50380516154064
   PubMed Web of Science ®Google Scholar
• SonnenbergFABurkmanRTSperoffL2005Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patchAm J Obstet Gynecol1921915671994
   PubMed Web of Science ®Google Scholar
• TerefeALarsonCP1993Modern contraception use in Ethiopia: does involving husbands make a difference?Am J Public Health831567718238680
   PubMed Web of Science ®Google Scholar
• TrussellJVaughanB1999Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family GrowthFam Plann Perspect31647210224544
   PubMedGoogle Scholar
• UrdlWApterDAlpersteinA2005Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraceptionEur J Obstet Gynecol Reprod Biol1212021016054963
   PubMed Web of Science ®Google Scholar
• WalsemannKMPerezAD2006Anxiety’s relationship to inconsistent use of oral contraceptivesHealth Educ Behav3319721416531513
   PubMed Web of Science ®Google Scholar
• WanGJBarnowskiCEAmbegaonkarBM2007Treatment satisfaction with a transdermal contraceptive patch or oral contraceptivesContraception75281417362706
   PubMed Web of Science ®Google Scholar
• WarnerPBancroftJ1990Factors related to self-reporting of the premenstrual syndromeBr J Psychiatry157249602224376
   PubMed Web of Science ®Google Scholar
• WeisbergFBouchardCMoreauM2005Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicenter studyJ Obstet Gynaecol Can27350915937609
   PubMedGoogle Scholar
• WesthoffCLHeartwellSEdwardsS2007Oral contraceptive discontinuation: do side effects matter?Am J Obstet Gynecol196412e1717403440
   PubMed Web of Science ®Google Scholar
• WhiteTJainJKStanczykFZ2005Effect of oral versus transdermal steroidal contraceptives on androgenic markersAm J Obstet Gynecol192200559
   Web of Science ®Google Scholar
• WHOAdherence to long-term therapies2003Evidence for actionGeneva, Switzerland
   Google Scholar
• YildizBO2008Oral contraceptives in polycystic ovary syndrome: risk-benefit assessmentSemin Reprod Med261112018181089
   PubMed Web of Science ®Google Scholar
• ZacurHAHedonBMansourD2002Integrated summary of Ortho Evra™/Evra™ contraceptive patch adhesion in varied climates and conditionsFertil Steril77S32511849634
   PubMed Web of Science ®Google Scholar
• ZiemanMGuillebaudJWeisbergE2002Contraceptive efficacy and cycle control with the Ortho Evra™/Evra™ transdermal system: the analysis of pooled dataFertil Steril77S13811849631
   PubMed Web of Science ®Google Scholar